Brinzolamide 1%
Clinical effectiveness of brinzolamide 1%–brimonidine 0.2% fixed combination for primary open-angle glaucoma and ocular hypertension
... Abstract: The main first-line treatment strategy for glaucoma is to reduce intraocular pressure (IOP) by topical ocular hypotensive medications, but many patients require multiple medica- tions for adequate IOP control. ...
7
Comparative Evaluation of the Efficacy of the Bimatoprost 0 03%, Brimonidine 0 2%, Brinzolamide 1%, Dorzolamide 2%, and Travoprost 0 004%/Timolol 0 5% Fixed Combinations in Patients Affected by Open Angle Glaucoma
... 0.5% fixed combination (Table 4). All the mean per- centage reduction after three months follow-up, due to these drugs, was not statistically significant, apart from brinzolamide 1%-timolol 0.5% fixed ...
5
Six-month results from a Phase III randomized trial of fixed-combination brinzolamide 1% + brimonidine 0.2% versus brinzolamide or brimonidine monotherapy in glaucoma or ocular hypertension
... Background: The objective of this study was to examine the safety and intraocular pressure (IOP)-lowering efficacy of a fixed combination of brinzolamide 1% + brimonidine 0.2% (BBFC) after six months of ...
8
Efficiency, safety, and patient preference of switching from dorzolamide 1%/timolol 0.5% to brinzolamide 1%/timolol 0.5% while maintaining the prostaglandin F2α analog
... Based on our criteria, 44 eyes from 44 patients were enrolled during the study period. Two patients dropped out of the study at 4 weeks due to stinging and blurred vision caused by brinzolamide 1%/timolol ...
8
Role of fixed-combination brinzolamide 1%/timolol 0.5% in the treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
... Abstract: Brinzolamide 1%/timolol ...hypertension. Brinzolamide/timolol has a favorable safety profile, with an incidence of ocular burning and stinging ...that brinzolamide 1%/timolol ...
7
Study of ocular hypotensive effect and tolerability of fixed-combination Brinzolamide 1% and brimonidine 0.2% in Indian eyes with open angle glaucoma
... Gandolfi et al (6) showed that The mean diurnal Intraocular pressure change from baseline with BBFC (least squares mean ± standard error -8.5 ± 0.16 mmHg) was noninferior to that with BRINZ +BRIM (–8.3 ± 0.16 mmHg; mean ...
126
Comparison of the latanoprost 0.005%/timolol 0.5% + brinzolamide 1% versus dorzolamide 1%/timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trial
... Methods: We conducted an open, randomized 12-week multicenter prospective study. We randomly allocated 39 patients who had been treated with three antiglaucoma eye drops ( prostaglandin F 2α analogues plus beta-blockers ...
7
Brinzolamide 1%/timolol versus dorzolamide 2%/timolol in the treatment of open-angle glaucoma or ocular hypertension: prospective randomized patient-preference study
... Methods: In this prospective, single-masked crossover study, patients were randomized 1:1 to BTFC-DTFC or DTFC-BTFC treatment sequences. Patients self-administered each medication for 7 days, with a 48-hour ...
8
Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
... Results: The IOP was 17.9±2.6 mmHg at baseline and 18.3±4.1 mmHg and 17.8±3.4 mmHg 1 month and 3 months after switching medications, respectively (P=0.633). The frequency of missing a dose was not different before ...
5
Efficacy and tolerability of the fixed combination of brinzolamide 1% and timolol 0.5% in daily practice
... of brinzolamide/timolol was overwhelm- ingly positive, with nearly 90% of patients judging its toler- ability to be either good or very ...to brinzolamide/timolol due to intolerance to their previous ...
8
Addition of a fixed combination of brinzolamide 1%/timolol 0.5% to prostaglandin monotherapy in patients with glaucoma or ocular hypertension
... visit 1; risk of visual field or visual acuity worsening as a consequence of trial participation in the investigator’s opinion; progressive retinal or optic nerve disease from any cause apart from glaucoma; women ...
6
DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF BRINZOLAMIDE AND TIMOLOL BY HPLC FROM OPHTHALMIC PREPARATION
... Glaucoma encompasses a wide clinical spectrum of disease, with the common pathophysiology of progressive optic neuropathy leading to visual field loss. Elevated intraocular pressure (IOP) is a key risk factor in disease ...
7
DESIGN OF OCULAR CONTROLLED RELEASE OCUSERTS OF BRINZOLAMIDE
... Topical Carbonic anhydrase inhibitors inhibit the production of aqueous humor and reduce the IOP by 16% to 22%. They work by inhibiting the enzyme carbonic anhydrase in the ciliary processes of the eye. Originally, CAIs ...
12
24-hour intraocular pressure in glaucoma patients randomized to receive dorzolamide or brinzolamide in combination with latanoprost
... dorzolamide 1% applied twice or thrice daily and brinzolamide 1% twice daily exerted significant 24-hour IOP-lowering activity when added to latanoprost in Japanese patients with POAG, OH, and ...
6
Combination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focus
... of brinzolamide 1% and brimonidine ...than brinzolamide or brimonidine monotherapy after 3 months of treat- ment in patients with open-angle glaucoma or ocular ...of brinzolamide and ...
12
Update and optimal use of a brinzolamide-timolol fixed combination in open-angle glaucoma and ocular hypertension
... Abstract: Glaucoma encompasses a wide clinical spectrum of disease, with the common pathophysiology of progressive optic neuropathy leading to visual field loss. Elevated intraocular pressure (IOP) is a key risk factor ...
6
Preference for a fixed combination of brinzolamide/timolol versus dorzolamide/ timolol among patients with open-angle glaucoma or ocular hypertension
... day 1, five patients receiving brinzolamide/ timolol reported five nonserious AEs: flu (n = 1), bitter taste (n = 2), and headache (n = ...to brinzolamide/timolol. All day 1 AEs were ...
6
Analytical method development and validation for the determination of Brinzolamide by RP-HPLC
... (4) Eissa, M. S.; Nour, I. M.; Elghobashy, M. R.; Shehata, M. A.; Chemistry department, A.; City, B.; El-, K. Validated Spectrophotometric Methods for Simultaneous Determination of Brinzolamide and Timolol Maleate ...
5
Safety and efficacy of a fixed versus unfixed brinzolamide/timolol combination in Japanese patients with open-angle glaucoma or ocular hypertension
... This was a Phase III, randomized, double-masked, multicenter, parallel-group, positive-controlled study (Figure 1) conducted at 34 sites in Japan. At the screening visit (week –4), patients gave their written ...
10
A novel ocular delivery of brinzolamide based on gellan gum: in vitro and in vivo evaluation
... Dialysis bag method was used for the in vitro study. The BLZ in situ gel at a volume of 100 μ L (or BLZ eye drops 100 μ L) was directly put into the dialysis bag (MWCO = 10,000), and then 50 μ L of TF was added. The ...
7